MERISSA FERRARO: Open Payments
NPI 1003248576 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$894 in 30 payments from 13 companies in 2025. Trend: 2023 $574 · 2024 $777 · 2025 $894
Food & beverage: $795Education: $99
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 3 | $188 |
| Janssen Biotech, Inc. | 6 | $183 |
| GENZYME CORPORATION | 3 | $106 |
| Incyte Corporation | 3 | $78 |
| ABBVIE INC. | 3 | $73 |
| Arcutis Biotherapeutics, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| PFIZER INC. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| UCB, Inc. | 1 | $25 |
Products named: VTAMA, TREMFYA, DUPIXENT, OPZELURA, SKYRIZI, Zoryve, Sotyktu, CIBINQO.
Industry payments across CA — which companies pay providers there.
